Shufeng Jiedu

A Traditional Chinese Medicine formulation.

Phase of research

Potential treatment - clinical evidence

How it helps

Other treatment

Drug status

Natural product

2
Supporting references
0
Contradictory references
12
AI-suggested references
0
Clinical trials

General information

Shufeng Jiedu is a Traditional Chinese Medicine formulation used for treatment of upper respiratory tract infections (Xia et al., 2020).


Synonyms

SFJD; SFJDC

 


Supporting references

Link Tested on Impact factor Notes Publication date
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.
Patients

Combination of lopinavir/ritonavir (Kaletra®), arbidol, and Shufeng Jiedu Capsule (SFJDC, a traditional Chinese medicine)

Mar/16/2020
Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study
3CLpro Small molecule Animal model Moderate severity Mild severity Mixed substance Cohort study In silico
in silico; patients; BALB/c mice (HCoV-229E virus infection only) 4.27

When added to the standard care, reduced symptomatic period of COVID-19 (cough and fatigue, but not fever and pharyngalgia) was observed. Sample size: 43 + 33 control. Dosage: Daily 6.24 g of dried herbal extract.


Oct/22/2020

AI-suggested references

Link Publication date
Potential Role of Gut Microbiota in Traditional Chinese Medicine against COVID-19.
Apr/09/2021
Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation.
Mar/11/2020
Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19)
May/11/2021
Influence of traditional Chinese medicines on the in vivo metabolism of lopinavir/ritonavir based on UHPLC-MS/MS analysis.
Jun/25/2021
Traditional Chinese medicine as an adjunctive therapy for mild and common COVID-19
Mar/14/2022
Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools.
Oct/30/2020
Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology
Sep/12/2020
Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking
Jan/15/2022
Efficacy and safety of Shufeng Jiedu capsule in the treatment of COVID-19
Dec/18/2020
Clinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study
Apr/15/2022
Systematic Analyses on the Potential Immune and anti-inflammatory Mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused Pneumonia
Dec/10/2020
Efficacy and potential mechanisms of Chinese herbal compounds in coronavirus disease 2019: advances of laboratory and clinical studies
Jan/13/2022